Infectious Diseases in the Immunocompromised Child
Transplant, Oncology and Other Immune Compromising Conditions
- 2nd Edition - October 3, 2026
- Latest edition
- Editor: William Steinbach
- Language: English
As the number of immunocompromised pediatric patients increases year by year, the need for authoritative guidance, clinically actionable strategies, and easy-to-find information in… Read more
Purchase options
Description
Description
As the number of immunocompromised pediatric patients increases year by year, the need for authoritative guidance, clinically actionable strategies, and easy-to-find information in this challenging area also continues to grow. Infectious Diseases in the Immunocompromised Child, 2nd Edition (formerly Pediatric Transplant and Oncology Infectious Diseases), provides up-to-date, targeted coverage of this complex field, compiled by world-renowned editors and authors into one convenient volume. An essential resource for infectious diseases physicians and others who care for pediatric patients undergoing transplant, cancer care, or treatment of dysregulated immunity, this newly expanded reference keeps you at the forefront of knowledge for these therapies so that you can anticipate the infectious presentations that often arise from them.
Key features
Key features
- Covers the must-know principles for diagnosing and managing opportunistic infections in immunocompromised populations and detailed aspects of their care—information not specifically covered in other books
- Provides authoritative coverage in a one-of-a kind compilation that reflects recent advances in hematopoietic cell and solid organ transplantation, as well as evolving chemotherapeutic regimens and immunomodulation therapies
- Focuses on practical, clinically actionable, and easy-to-find information, providing numerous figures, tables, and treatment algorithms for ease of use and significantly more images than the previous edition
- Covers an evolving immunocompromised patient population receiving novel immunomodulators, such as those with underlying rheumatological and autoinflammatory conditions, and discusses key topics such as microbiome implications in transplantation and oncology, antimicrobial resistant Gram-negative bacteria, EBV-associated post-transplant lymphoproliferative disorders, and many others
- Offers the insights and expertise of worldwide contributing authors—expert investigators and clinicians who are actively deciphering the mechanisms of disease and developing the latest approaches to optimal pediatric care
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date
Readership
Readership
Pediatric infectious disease specialists, ID specialists, academic/hospital-based pediatricians (pediatric hospitalists)
Table of contents
Table of contents
SECTION 1 GENERAL IMMUNOCOMPROMISED HOST INFECTION PRINCIPLES
Chapter 1 The Surgical and Immunosuppressive Basis for Infections in the Pediatric Solid Organ Transplant Recipient
Chapter 2 Immunologic Recovery and Basis for Infections in the Pediatric Hematopoietic Stem Cell Transplant Recipient
Chapter 3 Cancer and Antineoplastic Therapies and the Risk of Infection in the Pediatric Cancer Patient
Chapter 4 Biologics and Immune Modulators and Basis for Risk for Infection
Chapter 5 Principles of Pharmacokinetics in Immunocompromised Hosts
SECTION 2 COMMON IMMUNOCOMPROMISED HOST INFECTION SITUATIONS
Chapter 6 Infectious Disease Evaluation of Infants and Children Awaiting Solid Organ or Hematopoietic Stem Cell Transplant
Chapter 7 Donor Screening and Donor-Derived Infections in the Transplant Recipient
Chapter 8 Prevention of Infections in the Hematopoietic Cell Transplant Recipient
Chapter 9 Prevention of Infections in the Pediatric Solid Organ Transplantation Recipient
Chapter 10 Management Principles for Patients With Neutropenia
Chapter 11 Vaccination Issues for Transplantation, Chemotherapy, and Immune-Mediated Diseases
Chapter 12 Microbiome Implications in Immunocompromised Children
Chapter 13 Antimicrobial Stewardship in Immunocompromised Hosts
Chapter 14 Hospital Infection Prevention for Pediatric Immunocompromised Hosts
Chapter 15 Safe Living After Transplantation or Immunosuppressive Therapy
Chapter 16 Chimeric Antigen Receptor T-Cell Therapy
SECTION 3 SPECIFIC INFECTIONS IN TRANSPLANT RECIPIENTS AND ONCOLOGY PATIENTS
Chapter 17 Resistant Gram-Positive Bacteria
Chapter 18 Multidrug-Resistant Gram-Negative Infections in Transplant and Oncology Patients
Chapter 19 Bartonella, Legionella, Mycoplasma, and Ureaplasma
Chapter 20 Nontuberculous and Tuberculous Mycobacterium
Chapter 21 Clostridioides difficile Infection
Chapter 22 Cytomegalovirus
Chapter 23 Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder
Chapter 24 Herpes Simplex and Varicella-Zoster Viruses
Chapter 25 Human Herpesviruses 6, 7, and 8
Chapter 26 Respiratory Viruses
Chapter 27 Adenoviruses
Chapter 28 Measles
Chapter 29 BK and Other Polyomavirus-Associated Diseases in Children
Chapter 30 Gastrointestinal Viruses
Chapter 31 Hepatitis B Virus and Hepatitis C Virus
Chapter 32 Aspergillosis
Chapter 33 Mucormycosis
Chapter 34 Fusariosis, Scedosporiosis, Lomentosporiosis, and Other Invasive Mold Infections
Chapter 35 Candidiasis
Chapter 36 Cryptococcosis and Other Rare Invasive Yeasts Infections
Chapter 37 Endemic Fungal Infections: Histoplasmosis, Blastomycosis, and Coccidioidomycosis
Chapter 38 Pneumocystis Pneumonia
Chapter 39 Toxoplasma Gondii
Chapter 40 Strongyloides, Cryptosporidium, Babesia, Trypanosoma, and Other Parasitic Infections
Chapter 41 Nocardia and Actinomyces
Chapter 1 The Surgical and Immunosuppressive Basis for Infections in the Pediatric Solid Organ Transplant Recipient
Chapter 2 Immunologic Recovery and Basis for Infections in the Pediatric Hematopoietic Stem Cell Transplant Recipient
Chapter 3 Cancer and Antineoplastic Therapies and the Risk of Infection in the Pediatric Cancer Patient
Chapter 4 Biologics and Immune Modulators and Basis for Risk for Infection
Chapter 5 Principles of Pharmacokinetics in Immunocompromised Hosts
SECTION 2 COMMON IMMUNOCOMPROMISED HOST INFECTION SITUATIONS
Chapter 6 Infectious Disease Evaluation of Infants and Children Awaiting Solid Organ or Hematopoietic Stem Cell Transplant
Chapter 7 Donor Screening and Donor-Derived Infections in the Transplant Recipient
Chapter 8 Prevention of Infections in the Hematopoietic Cell Transplant Recipient
Chapter 9 Prevention of Infections in the Pediatric Solid Organ Transplantation Recipient
Chapter 10 Management Principles for Patients With Neutropenia
Chapter 11 Vaccination Issues for Transplantation, Chemotherapy, and Immune-Mediated Diseases
Chapter 12 Microbiome Implications in Immunocompromised Children
Chapter 13 Antimicrobial Stewardship in Immunocompromised Hosts
Chapter 14 Hospital Infection Prevention for Pediatric Immunocompromised Hosts
Chapter 15 Safe Living After Transplantation or Immunosuppressive Therapy
Chapter 16 Chimeric Antigen Receptor T-Cell Therapy
SECTION 3 SPECIFIC INFECTIONS IN TRANSPLANT RECIPIENTS AND ONCOLOGY PATIENTS
Chapter 17 Resistant Gram-Positive Bacteria
Chapter 18 Multidrug-Resistant Gram-Negative Infections in Transplant and Oncology Patients
Chapter 19 Bartonella, Legionella, Mycoplasma, and Ureaplasma
Chapter 20 Nontuberculous and Tuberculous Mycobacterium
Chapter 21 Clostridioides difficile Infection
Chapter 22 Cytomegalovirus
Chapter 23 Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder
Chapter 24 Herpes Simplex and Varicella-Zoster Viruses
Chapter 25 Human Herpesviruses 6, 7, and 8
Chapter 26 Respiratory Viruses
Chapter 27 Adenoviruses
Chapter 28 Measles
Chapter 29 BK and Other Polyomavirus-Associated Diseases in Children
Chapter 30 Gastrointestinal Viruses
Chapter 31 Hepatitis B Virus and Hepatitis C Virus
Chapter 32 Aspergillosis
Chapter 33 Mucormycosis
Chapter 34 Fusariosis, Scedosporiosis, Lomentosporiosis, and Other Invasive Mold Infections
Chapter 35 Candidiasis
Chapter 36 Cryptococcosis and Other Rare Invasive Yeasts Infections
Chapter 37 Endemic Fungal Infections: Histoplasmosis, Blastomycosis, and Coccidioidomycosis
Chapter 38 Pneumocystis Pneumonia
Chapter 39 Toxoplasma Gondii
Chapter 40 Strongyloides, Cryptosporidium, Babesia, Trypanosoma, and Other Parasitic Infections
Chapter 41 Nocardia and Actinomyces
Product details
Product details
- Edition: 2
- Latest edition
- Published: October 3, 2026
- Language: English
About the editor
About the editor
William Steinbach
Editor
Affiliations and expertise
Professor of Pediatrics, Robert H. Fiser, Jr., MD Endowed Chair in Pediatrics, Chair, Department of Pediatrics, Associate Dean for Child Health, College of Medicine, University of Arkansas for Medical Sciences; Pediatrician-in-Chief, Arkansas Children’s Little Rock, Arkansas, USA